Takeda pulled its marketing application in the EU for alogliptin: <a href="http://www.genengnews.com/news/bnitem.aspx?name=55661199" rel="nofollow" target="_blank">http://www.genengnews.com/news/bnitem.aspx?name=55661199</a>